crocin-1/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“The data analysis using ANCOVA showed that supplementation with crocin for 8 weeks significantly lowered hs-CRP levels (p-value= 0.01).”
Quoted verbatim from Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 15 mg crocin tablet twice daily (30 mg/day)
- Population
- Patients with multiple sclerosis; crocin 15 mg twice daily (30 mg/day) versus placebo
Effects of crocin on inflammatory biomarkers and mental health status in patients with multiple sclerosis: A randomized, double-blinded clinical trial.2024PMID:38306888Permalink
Keep reading
- Everything the graph holds on crocin-1
- Every compound studied against C-reactive protein concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PJN9982400XZCSKDEAG7TR